These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33634940)
1. Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation. Bao Y; Suvesh M; Li X; Bai X; Li H; Li X; Xu D; Liu L Mol Carcinog; 2021 Apr; 60(4):252-264. PubMed ID: 33634940 [TBL] [Abstract][Full Text] [Related]
2. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors. Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709 [TBL] [Abstract][Full Text] [Related]
3. The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Hu B; Xiong Y; Ni R; Wei L; Jiang D; Wang G; Wu D; Xu T; Zhao F; Zhu M; Wan C Mol Cell Biochem; 2014 Nov; 396(1-2):175-85. PubMed ID: 25081333 [TBL] [Abstract][Full Text] [Related]
4. Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis. Nguyen DQ; Hoang DH; Nguyen TTV; Ho HD; Huynh V; Shin JH; Ly QT; Thi Nguyen DD; Ghoda L; Marcucci G; Nguyen LXT J Cell Physiol; 2019 Aug; 234(10):17612-17621. PubMed ID: 30793766 [TBL] [Abstract][Full Text] [Related]
5. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling. Lu WJ; Chua MS; So SK Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681 [TBL] [Abstract][Full Text] [Related]
6. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma. Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163 [TBL] [Abstract][Full Text] [Related]
7. EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells. Pisapia L; Barba P; Cortese A; Cicatiello V; Morelli F; Del Pozzo G Int J Oncol; 2015 Aug; 47(2):481-9. PubMed ID: 26081906 [TBL] [Abstract][Full Text] [Related]
8. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma. Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879 [TBL] [Abstract][Full Text] [Related]
9. Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells. Ko HR; Chang YS; Park WS; Ahn JY Int J Cancer; 2016 Sep; 139(6):1202-8. PubMed ID: 27130196 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862 [TBL] [Abstract][Full Text] [Related]
11. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway. Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L Int J Oncol; 2013 Mar; 42(3):1001-10. PubMed ID: 23354417 [TBL] [Abstract][Full Text] [Related]
12. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766 [TBL] [Abstract][Full Text] [Related]
13. Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis. Okada M; Jang SW; Ye K J Biol Chem; 2007 Dec; 282(50):36744-54. PubMed ID: 17951246 [TBL] [Abstract][Full Text] [Related]
14. p48 Ebp1 acts as a downstream mediator of Trk signaling in neurons, contributing neuronal differentiation. Kwon IS; Ahn JY Neurochem Int; 2011 Feb; 58(2):215-23. PubMed ID: 21145366 [TBL] [Abstract][Full Text] [Related]
15. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway. Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619 [TBL] [Abstract][Full Text] [Related]
16. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression. Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504 [TBL] [Abstract][Full Text] [Related]
17. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways. Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the N-terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48. Ko HR; Kim CK; Ahn JY Mol Carcinog; 2015 Nov; 54(11):1283-91. PubMed ID: 25154617 [TBL] [Abstract][Full Text] [Related]
19. The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2. Lai WL; Hung WY; Wong LL; Zhou Y; Leong VY; Lee JM; Ng IO; Jin DY; Ching YP Hepatology; 2012 Nov; 56(5):1770-81. PubMed ID: 22610972 [TBL] [Abstract][Full Text] [Related]
20. Ebp1 isoforms distinctively regulate cell survival and differentiation. Liu Z; Ahn JY; Liu X; Ye K Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10917-22. PubMed ID: 16832058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]